(Q27852737)

13 November 2016

title

The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome? (English)

1 reference

PubMed

PubMed publication ID

13 November 2016

2

Aldona Kowalska

0 references

Stanisław Góźdź

8

Stanisław Góźdź

0 references

Agnieszka Walczyk

1

Agnieszka Walczyk

0 references

Artur Kowalik

3

Artur Kowalik

0 references

Elżbieta Wypiórkiewicz

5

Elżbieta Wypiórkiewicz

0 references

Renata Chodurska

6

Renata Chodurska

0 references

Liliana Pięciak

7

Liliana Pięciak

0 references

Jacek Sygut

4

Mutations of the BRAF gene in human cancer

Jacek Sygut

0 references

publication date

June 2014

0 references

published in

Clinical Endocrinology

0 references

volume

80

0 references

issue

6

0 references

page(s)

899-904

0 references

cites work

1 reference

BRAF mutation in thyroid cancer

21 January 2018

1 reference

The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer

21 January 2018

1 reference

BRAFV600E mutation and papillary thyroid cancer: chicken or egg?

21 January 2018

1 reference

The prevalence and prognostic value of BRAF mutation in thyroid cancer

21 January 2018

1 reference

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

21 January 2018

1 reference

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients

21 January 2018

1 reference

BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications

21 January 2018

1 reference

Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases

21 January 2018

1 reference

Controversies in primary treatment of low-risk papillary thyroid cancer

21 January 2018

1 reference

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population.

21 January 2018

1 reference

A piece of the puzzle: what does BRAF status mean in the management of patients with papillary thyroid carcinoma?

21 January 2018

1 reference

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

21 January 2018

1 reference

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions

21 January 2018

1 reference

BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation.

21 January 2018

1 reference

Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.

21 January 2018

1 reference

Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers

21 January 2018

1 reference

The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma.

21 January 2018

1 reference

A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome.

21 January 2018

1 reference

The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12386

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24354346

1 reference

Consolidated OpenCitations Corpus – April 2017